Steward Partners Investment Advisory
ESPR icon

Steward Partners Investment Advisory’s Esperion Therapeutics ESPR Stock Holding History

Steward Partners Investment Advisory’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.16K Hold
1,000
– – ﹤0.01% 4122
2026
Q1 		$2.74K Hold
1,000
– – ﹤0.01% 3956
2025
Q4 		$3.7K Hold
1,000
– – ﹤0.01% 3786
2025
Q3 		$2.65K Hold
1,000
– – ﹤0.01% 3847
2025
Q2 		$984 Hold
1,000
– – ﹤0.01% 3864
2025
Q1 		$1.44K Hold
1,000
– – ﹤0.01% 3708
2024
Q4 		$2.2K Hold
1,000
– – ﹤0.01% 3613
2024
Q3 		$1.65K Hold
1,000
– – ﹤0.01% 3464
2024
Q2 		$2.22K Buy
+1,000
New +$2.35K ﹤0.01% 3265
2021
Q1 		– Sell
-1,100
Closed -$29K – 3443
2020
Q4 		$29K Sell
1,100
-850
-44% -$25.5K ﹤0.01% 1923
2020
Q3 		$72K Buy
1,950
+450
+30% +$17.8K ﹤0.01% 1342
2020
Q2 		$77K Hold
1,500
– – ﹤0.01% 1250
2020
Q1 		$47K Sell
1,500
-600
-29% -$31.7K ﹤0.01% 1284
2019
Q4 		$125K Sell
2,100
-650
-24% -$29.2K ﹤0.01% 1035
2019
Q3 		$100K Sell
2,750
-800
-23% -$31.7K ﹤0.01% 1089
2019
Q2 		$165K Buy
+3,550
New +$167K 0.01% 874
2018
Q2 		– Sell
-100
Closed -$7K – 2470
2018
Q1 		$7K Hold
100
– – ﹤0.01% 1687
2017
Q4 		$6K Buy
+100
New +$5.38K ﹤0.01% 1459

Other funds holding ESPR

Glazer Capital LLC
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Arbitrage
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return

Steward Partners Investment Advisory's ESPR Position: Q2 2026 in Review

Steward Partners Investment Advisory held its Esperion Therapeutics (ESPR) position steady in Q2 2026 at 1,000 shares worth $3.16K. The position accounts for ﹤0.01% of the portfolio, ranked #4122.

Steward Partners Investment Advisory first reported a position in ESPR in Q4 2017 and has held it in 18 quarters since. The position peaked at $165K in Q2 2019. 192 funds tracked by Wall St. Rank hold ESPR as of Q2 2026.

  • Steward Partners Investment Advisory held 1,000 shares of Esperion Therapeutics worth $3.16K as of Q2 2026.
  • Steward Partners Investment Advisory left its Esperion Therapeutics share count unchanged in Q2 2026.
  • Esperion Therapeutics made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #4122 holding.
  • Steward Partners Investment Advisory first reported a position in Esperion Therapeutics in Q4 2017 and has held it in 18 quarters since.
  • Steward Partners Investment Advisory's Esperion Therapeutics position peaked at $165K in Q2 2019.
  • 192 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.